Related Experiment Video
Updated: Aug 25, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
Understanding co-morbidities affecting children with epilepsy
1Virginia Commonwealth University/Medical College of Virginia, Richmond, VA 23298-0565, USA.
Insights
Childhood epilepsy often co-occurs with conditions like ADHD and autism. Effective treatment requires managing both epilepsy and these associated disorders for optimal patient outcomes.
Area of Science:
- Pediatric Neurology
- Child Psychiatry
Background:
- Co-morbid conditions are common in childhood epilepsy, impacting both the disorder and its management.
- Epilepsy and its treatments can also influence associated conditions, creating complex interrelationships.
Purpose of the Study:
- To highlight the significant co-morbidities associated with childhood epilepsy.
- To emphasize the importance of understanding the interplay between epilepsy, co-morbidities, and treatments in pediatric patients.
Main Methods:
- Review of existing literature on childhood epilepsy and co-morbidities.
- Analysis of the impact of epilepsy and antiepileptic drugs (AEDs) on associated conditions.
Main Results:
- Common co-morbidities include ADHD, autism, developmental disabilities, accidental injury, migraine, and depression/anxiety.
- Individualized treatment plans considering co-morbidities and concomitant medications are crucial.
Conclusions:
- Optimal management of pediatric epilepsy necessitates a comprehensive approach addressing co-morbidities.
- Certain newer AEDs may offer benefits for children with epilepsy and co-existing disorders, potentially ameliorating both conditions.
Abstract:
Co-morbid conditions frequently occur in childhood epilepsy and may significantly affect epilepsy and its treatment. Similarly, epilepsy and antiepileptic drugs (AEDs) may affect these associated conditions. Co-morbidities that have a significant association with childhood epilepsy include attention-deficit/hyperactivity disorder, autism, developmental disabilities, accidental injury, migraine, and depression/anxiety. Understanding the interrelationships among co-morbidities, epilepsy, and their treatments is essential to optimal management of pediatric patients. Treatment should be individualized with consideration for specific co-morbidities and concomitant medications. Key treatment goals are to achieve seizure control and optimal physical and cognitive function using the simplest possible AED regimen. The clinician should consider whether an antiepileptic treatment can be chosen that also ameliorates the co-morbid condition. Newer AEDs, such as lamotrigine, topiramate, gabapentin, oxcarbazepine, and tiagabine, may benefit children with epilepsy and some co-morbid disorders.
More Related Videos
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Related Concept Videos
Epilepsy ll: Types
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures l: Introduction
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Seizures ll: Types